Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients

American Journal of Clinical Nutrition

Volumn 102, Issue 5, 2015, Pages 1051-1058

  Fritsch, Maria ^a,c   Koliaki, Chrysi ^a,b,d   Livingstone, Roshan ^a   Phielix, Esther ^a   Bierwagen, Alessandra ^a,d   Meisinger, Markus ^a   Jelenik, Tomas ^a,d   Strassburger, Klaus ^a,d   Zimmermann, Stefanie ^a,d   Brockmann, Katharina ^a,d   Wolff, Christina ^a,d   Hwang, Jong Hee ^a,d   Szendroedi, Julia ^a,b,d   Roden, Michael ^a,b,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Department of Orthopedic Surgery   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d German Center of Diabetes Research DZD e V   (Germany)

Author keywords

Hepatic steatosis; Mitochondrial function; Mixed meal test; Phosphorus magnetic resonance spectroscopy; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; C PEPTIDE; FATTY ACID; GAMMA ADENOSINE TRIPHOSPHATE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE OXIDASE; INSULIN; METFORMIN; PHOSPHATE; PHOSPHORUS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SULFONYLUREA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID; ADENOSINE TRIPHOSPHATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; ENERGY METABOLISM; FAT CONTENT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MUSCLE BIOPSY; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VASTUS LATERALIS MUSCLE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADULT; AGED; ALLOSTASIS; BIOPSY; BLOOD; CALORIMETRY; COHORT ANALYSIS; COMPLICATION; ENZYMOLOGY; FEMALE; LIVER; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; POSTPRANDIAL STATE; QUADRICEPS FEMORIS MUSCLE;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; ALLOSTASIS; BIOPSY; BODY MASS INDEX; CALORIMETRY, INDIRECT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ELECTRON TRANSPORT COMPLEX I; ENERGY METABOLISM; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; POSTPRANDIAL PERIOD; QUADRICEPS MUSCLE;

EID: 84946068429     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.107599     Document Type: Article

References (45)

1. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013;5:1544-60.
2. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012;142:711-25.e6.
3. Yki-Järvinen H, Makimattila S. Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues. Diabetologia 1997;40(Suppl 2):S141-4.
4. Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhausl W. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002;51:3025-32.
5. Krssak M, Brehm A, Bernroider E, Anderwald C, Nowotny P, Dalla Man C, Cobelli C, Cline GW, Shulman GI, Waldhausl W, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 2004;53:3048-56.
6. Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, Krssak M, Nowotny P, Wolzt M, Waldhausl W, Roden M. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007;4:e154.
7. Phielix E, Jelenik T, Nowotny P, Szendroedi J, Roden M. Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial. Diabetologia 2014;57:572-81.
8. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 2007;104:12587-94.
9. Jelenik T, Roden M. Mitochondrial plasticity in obesity and diabetes mellitus. Antioxid Redox Signal 2013;19:258-68.
10. Zhang D, Liu ZX, Choi CS, Tian L, Kibbey R, Dong J, Cline GW, Wood PA, Shulman GI. Mitochondrial dysfunction due to longchain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA 2007;104: 17075-80.
11. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 2010;52:727-36.
12. Perfield JW 2nd, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient ob/ob mice. J Obes 2013;2013:296537.
13. Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, Herder C, Carstensen M, Krausch M, Knoefel WT, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic Fatty liver is lost in steatohepatitis. Cell Metab 2015;21:739-46.
14. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
15. Koliaki C, Roden M. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol 2013;379:35-42.
16. Szendroedi J, Yoshimura T, Phielix E, Koliaki C, Marcucci M, Zhang D, Jelenik T, Muller J, Herder C, Nowotny P, et al. Role of diacylglycerol activation of PKCtheta in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci USA 2014;111:9597-602.
17. Schadewaldt P, Nowotny B, Strassburger K, Kotzka J, Roden M. Indirect calorimetry in humans: a postcalorimetric evaluation procedure for correction of metabolic monitor variability. Am J Clin Nutr 2013; 97:763-73.
18. Szendroedi J, Chmelik M, Schmid AI, Nowotny P, Brehm A, Krssak M, Moser E, Roden M. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 2009;50:1079-86.
19. Kalant N, Kuyumjian J, Luna F, Nastase C. Hepatic glucose extraction in normal and diabetic man. Metabolism 1987;36:513-20.
20. Nowotny B, Nowotny PJ, Strassburger K, Roden M. Precision and accuracy of blood glucose measurements using three different instruments. Diabet Med 2012;29:260-5.
21. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, WaldhauslW, Roden M. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 2000;46:950-4.
22. Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, et al. Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans. Diabetes 2013;62:2240-8.
23. Laufs A, Livingstone R, Nowotny B, Nowotny P, Wickrath F, Giani G, Bunke J, Roden M, Hwang JH. Quantitative liver P magnetic resonance spectroscopy at 3T on a clinical scanner. Magn Reson Med 2014;71: 1670-5.
24. Szendroedi J, Anderwald C, Krssak M, Bayerle-Eder M, Esterbauer H, Pfeiler G, Brehm A, Nowotny P, Hofer A, Waldhausl W, et al. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care 2009;32:209-14.
25. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Croce LS, Grigolato P, Paoletti S, de Bernard B, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995;5:281-5.
26. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007;293:E1663-9.
27. Dunn OJ. Multiple comparisons among means. J Am Stat Assoc 1961; 56:52-64.
28. Konietschke F, Bosiger S, Brunner E, Hothorn LA. Are multiple contrast tests superior to the ANOVA? Int J Biostat 2013;9:63-73.
29. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999;282:1659-64.
30. Schmid AI, Szendroedi J, Chmelik M, Krssak M, Moser E, Roden M. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 2011;34:448-53.
31. Sunny NE, Parks EJ, Browning JD, Burgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 2011;14:804-10.
32. Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, Bantle JP, Johnson RJ, Diehl AM, Clark JM, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012;56:952-60.
33. Nair S, P Chacko V, Arnold C, Diehl AM. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol 2003;98:466-70.
34. Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, Shimizu A, Kurita S, Takeshita Y, Ando H, Honda M, et al. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity (Silver Spring) 2008;16:2601-9.
35. Butterworth PJ, Younus MJ. Uptake of phosphate by rat hepatocytes in primary culture: a sodium-dependent system that is stimulated by insulin. Biochim Biophys Acta 1993;1148:117-22.
36. Liu HY, Yehuda-Shnaidman E, Hong T, Han J, Pi J, Liu ZWC. Prolonged exposure to insulin suppresses mitochondrial production in primary hepatocytes. J Biol Chem 2009;284:14087-95.
37. Poussin C, Ibberson M, Hall D, Ding J, Soto J, Abel ED, Thorens B. Oxidative phosphorylation flexibility in the liver of mice resistant to high-fat diet-induced hepatic steatosis. Diabetes 2011;60:2216-24.
38. Jelenik T, Sequaris G, Kaul K, Ouwens DM, Phielix E, Kotzka J, Knebel B, Weiss J, Reinbeck AL, Janke L, et al. Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes. Diabetes 2014;63:3856-67.
39. Meyerhoff DJ, Boska MD, Thomas AM, Weiner MW. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy. Radiology 1989;173:393-400.
40. Corbin IR, Ryner L, Singh H, Minuk G. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol 2004;287:G379-84.
41. Szendroedi J, Kaul K, Kloock L, Strassburger K, Schmid AI, Chmelik M, Kacerovsky M, Kacerovsky-Bielesz G, Prikoszovich T, Brehm A, et al. Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans. Diabetes Care 2014;37:468-74.
42. Szendroedi J, Zwettler E, Schmid AI, Chmelik M, Pacini G, Kacerovsky G, Smekal G, Nowotny P, Wagner O, Schnack C, et al. Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. PLoS One 2008;3:e3958.
43. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-2.
44. Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 2014;510:542-6.
45. Larsen S, Rabol R, Hansen CN, Madsbad S, Helge JW, Dela F.Metformintreated patients with type 2 diabetes have normal mitochondrial complex I respiration. Diabetologia 2012;55:443-9.